Ultima-AOD9604 5mg

MANUFACTURER Ultima Pharmaceuticals - USA
WAREHOUSE USA Warehouse 5
SUBSTANCE Anti-Obesity Drug-9604

Your order will be shipped discreetly without branding for your peace of mind.

AOD 9604 is an innovative peptide derived from Growth Hormone, featuring a unique structure of 191 amino acids. This specialized peptide, known as GH Frag 176-191 or AOD 9604, is crafted from the final 15 amino acids of the Growth Hormone sequence.

Recognized as one of the most powerful peptides for weight loss, AOD 9604 not only supports fat reduction but also boosts metabolism and offers a range of other health benefits.

Gland Stimulated: Pituitary Gland

• Significantly reduces body fat
• Promotes fat release from obese fat cells while sparing lean cells
• Replicates the natural fat metabolism regulation of growth hormone
• Maintains stable blood sugar levels and does not affect growth
• Stimulates lipolysis (fat breakdown)
• Inhibits lipogenesis, preventing the conversion of non-fatty foods into body fat
• Supports cartilage repair and regeneration, especially when paired with peptide BPC 157.

Mechanism of Action:

AOD-9604, also known as Tyr-hGH Frag 176-191, is renowned for its remarkable fat-burning properties without increasing appetite. Unlike traditional growth hormone, it does not influence blood sugar levels or tissue growth (Heffernan 2001, Ng 2000). AOD-9604 activates fat oxidation through a unique mechanism that bypasses hGH receptors, promoting fat release from obese cells while minimizing new fat formation and enhancing fat breakdown. It is particularly effective in targeting abdominal fat.

For those seeking fat loss, it?s advisable to avoid GHRP products (like GHRP-6 or GHRP-2), as they can increase hunger and cortisol levels. AOD-9604, on the other hand, does not lead to heightened appetite or cortisol spikes, making it an excellent choice for weight management.

AOD 9604 Research:

Developed in the 1990s by Professor Frank Ng at Monash University in Australia, AOD-9604 (Advanced Obesity Drug) was designed to harness the fat-burning benefits of human growth hormone (HGH) without the muscle growth effects.

Recent studies have uncovered additional regenerative properties of AOD 9604 associated with growth hormone, with ongoing clinical trials investigating its potential for treating osteoarthritis, hypercholesterolemia, and aiding in bone and cartilage repair.

Results from oral glucose tolerance tests indicate that, unlike HGH, AOD 9604 does not negatively impact carbohydrate metabolism. No AOD 9604 antibodies have been detected in patient assays, and clinical trials report no serious adverse effects or withdrawal symptoms relating to AOD 9604 use.

Conclusion:

AOD 9604 boasts an impressive safety and tolerability profile, akin to that of a placebo, free from the adverse side effects commonly associated with full-length hGH treatments. With a stellar safety record, AOD 9604 has recently achieved Human GRAS status in the USA.